Skip to content
10-Q

Quarterly Report

ARCTURUS THERAPEUTICS HOLDINGS INC. ARCT

0000950170-25-069210

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 6, 2025 27.12M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $15M
Current Liabilities Q1 2025 · Mar 31, 2025 $49.41M
Current Liabilities Q1 2025 · Dec 31, 2024 $65.49M
Total Liabilities Q1 2025 · Mar 31, 2025 $98.03M
Total Liabilities Q1 2025 · Dec 31, 2024 $103.09M
Current Assets Q1 2025 · Mar 31, 2025 $278.79M
Current Assets Q1 2025 · Dec 31, 2024 $305.98M
Total Assets Q1 2025 · Mar 31, 2025 $331.79M
Total Assets Q1 2025 · Dec 31, 2024 $344.07M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $237.03M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $288.4M
Shares Diluted Q1 2025 · Mar 31, 2024 26.88M sh
Capex Q1 2025 · Mar 31, 2024 $240K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$5.56M
Stockholders Equity Q1 2025 · Mar 31, 2024 $263.97M
Stockholders Equity Q1 2025 · Dec 31, 2023 $278.51M
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.00
Eps Basic Q1 2025 · Mar 31, 2024 −$1.00
Sga Expense Q1 2025 · Mar 31, 2024 $14.85M
Rd Expense Q1 2025 · Mar 31, 2024 $53.57M
Net Income Q1 2025 · Mar 31, 2024 −$26.82M
Operating Income Q1 2025 · Mar 31, 2024 −$30.41M
Revenue Q1 2025 · Mar 31, 2024 $38.01M